CC
PCRX icon

Clearline Capital’s Pacira BioSciences PCRX Stock Holding History

Clearline Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-136,658
Closed -$3.99M – 155
2024
Q1 		$3.99M Sell
136,658
-194,119
-59% -$5.67M 0.19% 60
2023
Q4 		$11.2M Buy
330,777
+31,485
+11% +$1.06M 0.68% 25
2023
Q3 		$9.18M Buy
+299,292
New +$9.18M 0.79% 35